Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_878c62007c7a9fe08012c9f5caf783e8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_557af47859f7449220cf617f9aaca5ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b53ec12f3a621f949b542df548042e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_523fea83e6020e2de38661e85bc1fbcf |
publicationDate |
2022-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022229705-A1 |
titleOfInvention |
Use of therapeutic plasma exchange and low volume plasma exchange for the treatment of a cognitive impairment |
abstract |
The present invention relates to a composition comprising human albumin at a concentration of between 5 % (w/v) and 25 % (w/v) for the treatment of a cognitive impairment by therapeutic plasma exchange (TPE) and low-volume plasma exchange (LVPE) in a patient in need thereof, where said patient has a Mini Mental State Examination (MMSE) greater or equal to 15. |
priorityDate |
2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |